Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,001,599 | 929,166 | 751,652 | 634,409 | 781,308 |
| Cost of Goods | 170,462 | 138,132 | 124,935 | 105,832 | 96,309 |
| Gross Profit | 831,137 | 791,034 | 626,717 | 528,577 | 684,999 |
| Operating Expenses | 951,864 | 898,327 | 889,000 | 913,204 | 819,276 |
| Operating Income | -120,265 | -107,161 | -261,348 | -383,795 | -133,968 |
| Other Income | 21,961 | 1,241 | 17,922 | 33,023 | 363,306 |
| Pre-tax Income | -98,304 | -105,920 | -243,426 | -350,772 | 229,338 |
| Income Tax | 23,046 | 14,485 | 7,724 | 16,781 | 13,925 |
| Net Income Continuous | -121,350 | -120,405 | -251,150 | -367,553 | 215,413 |
| Net Income | $-121,350 | $-120,405 | $-251,150 | $-367,553 | $215,413 |
| EPS Basic Total Ops | -1.15 | -1.15 | -2.41 | -3.53 | 2.06 |
| EPS Basic Continuous Ops | -1.15 | -1.15 | -2.41 | -3.52 | 2.06 |
| EPS Diluted Total Ops | -1.15 | -1.15 | -2.41 | -3.48 | 2.01 |
| EPS Diluted Continuous Ops | -1.15 | -1.15 | -2.41 | -3.47 | 2.01 |
| EPS Diluted Before Non-Recurring Items | -1.15 | -1.15 | -2.41 | N/A | N/A |
| EBITDA(a) | $-48,973 | $-82,230 | $-236,055 | $-359,976 | $-112,458 |